MétaCan
Menu
Back to cohort
Record W4410007150 · doi:10.1016/j.jscai.2025.103515

Global Results From the Optimize PRO Study: Standardized TAVR Technique and Care Pathway

2025· article· en· W4410007150 on OpenAlexaffabout
Kendra J. Grubb, Hemal Gada, Douglas Fraser, Josep Rodés‐Cabau, Tamim Nazif, Suneet Mittal, Danny Dvir, Emmanuel Teíger, Lang Lin, Joshua D. Rovin, Ramzi F. Khalil, Ibrahim Sultan, M. Yudi, Blake Gardner, David H. Lorenz, Stanley Chetcuti, Nainesh Patel, James E. Harvey, Paul Mahoney, Deepak Talreja, Carlo Trani, Darren Mylotte, Brian S. Schwartz, Zubair Jafar, Jan Van der Heyden, Diego Maffeo, Gerald Yong, César Morı́s, John Wang, Robert Gooley, Katie Flor, Yu Jung Yeh, Steven J. Yakubov

Bibliographic record

VenueJournal of the Society for Cardiovascular Angiography & Interventions · 2025
Typearticle
Languageen
FieldMedicine
TopicCardiac Valve Diseases and Treatments
Canadian institutionsUniversité Laval
FundersMedtronicAbbott Laboratories
KeywordsReliability engineeringMedicineEngineering

Abstract

fetched live from OpenAlex

Background: The safety and efficacy of utilizing standardized implant protocols and care pathways are limited in large global prospective studies of transcatheter aortic valve replacement (TAVR), and institutional variability remains. This analysis aims to report 30-day outcomes from the global Optimize PRO study evaluating valve performance and procedural outcomes using an "optimized" TAVR care pathway and the cusp overlap technique (COT) in patients receiving Evolut PRO/PRO+ valves. Methods: The Optimize PRO study is a multicenter, postmarket, prospective study conducted in 50 centers in the United States, Canada, Europe, the Middle East, and Australia. Patients with symptomatic severe aortic stenosis and no preexisting pacemakers underwent TAVR with standardized optimized preprocedure, periprocedure, and postprocedure pathways. Results: There were 653 patients with attempted TAVR implants, a mean age of 79.1 ± 6.5 years, and a mean Society of Thoracic Surgeons predictive risk of mortality of 3.2% ± 2.5%. The primary 30-day end point of all-cause mortality or all stroke was 5.1%, all-cause mortality 0.8%, and disabling stroke 1.7%. The new 30-day permanent pacemaker implantation rate was 6.4% with 4-step COT compliance and 11.1% overall. At discharge, there were no instances of moderate or severe aortic regurgitation, and 76.2% of patients had none/trace aortic regurgitation. The median length of stay was 2 days. Conclusions: The Optimize PRO study demonstrated low rates of new permanent pacemaker implantation and no moderate to severe aortic regurgitation after TAVR with Evolut PRO/PRO+ using COT and perioperative protocols in a global cohort of severe aortic stenosis patients. Best practices resulted in consistent implantation depth and low complication rates.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.006
metaresearch head score (Gemma)0.006
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.006
Threshold uncertainty score0.032

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0060.006
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0000.001
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.016
GPT teacher head0.330
Teacher spread0.314 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueJournal of the Society for Cardiovascular Angiography & InterventionsSame topicCardiac Valve Diseases and TreatmentsFrench-language works237,207